This bill would require the U.S. to withhold funding for the UNRWA (United Nations refugee agency for Palestinians) unless the State Department certifies UNRWA staff, materials, and facilities comply with specific conditions. Key conditions include confirming no ties to terrorism or anti-Israel rhetoric (like denying Israel's right to exist or promoting BDS), no misuse of UNRWA resources for terrorist activities, and adherence to international financial audits. It also caps U.S. contributions to UNRWA at levels comparable to Arab League countries and mandates annual reports to Congress on phasing out UNRWA support. These changes directly affect U.S. foreign aid decisions for Palestinian refugees in Jordan, Lebanon, Syria, Gaza, and the West Bank.
Second Chance at Life Act of 2023 This bill requires abortion providers to disclose information about the possibility of reversing a medication abortion. This is a procedure that uses a medication regimen to terminate a pregnancy, typically with a two-drug protocol. Providers must inform patients that it may be possible to reverse the effects of a medication abortion after taking the first drug. They must also let patients know that more information and assistance is available on the Department of Health and Human Services (HHS) website. At least 24 hours before the procedure, the provider must share this information with the patient in person or by telephone. The provider must also include the information in written discharge instructions after the first drug is dispensed. The bill sets out an exception to these notification requirements when an abortion is necessary to resolve a physical injury or condition that threatens the life of the woman. The provider must document the circumstances giving rise to the exception in the patient's medical file. Furthermore, providers must post signs with this information in their offices or facilities, and HHS must maintain information about reversing medication abortions on its website.
Disposable ENDS Product Enforcement Act of 2023 This bill requires the Food and Drug Administration (FDA) to update its enforcement guidance regarding Electronic Nicotine Delivery System (ENDS) products to include certain disposable ENDS products. In April 2020, the FDA published revised guidance on how it intends to prioritize enforcement resources with respect to ENDS products that do not have premarket authorization (i.e., that have not received FDA approval). The guidance specifies that the FDA intends to prioritize enforcement against (1) flavored, cartridge-based ENDS products (except for tobacco or menthol flavored products); (2) other ENDS products for which the manufacturer has not taken adequate measures to prevent access to minors; (3) any ENDS products that are targeted or promoted towards minors; and (4) any ENDS products for which the manufacturer has not submitted an application for market approval or did not receive approval. For purposes of this guidance, cartridge-based ENDS products do not include disposable products that are completely self-contained . The bill requires the FDA to incorporate these products, including nicotine products that are not derived from tobacco, into its enforcement priorities. The bill additionally specifies that the FDA may prioritize enforcement against these products in advance of updating the guidance. The FDA must also annually report on its enforcement actions with respect to these products.
HR 902, "Ellie’s Law," authorizes $10 million annually from fiscal years 2024 through 2028 for the National Institute of Neurological Disorders and Stroke to conduct broader research on unruptured brain aneurysms. The funding aims to study diverse patient populations by age, sex, and race, supplementing existing research budgets without replacing them. This bill directly affects researchers and future patients by increasing federal investment in a condition impacting 6.6 million Americans, with current federal spending at only $2.08 per affected person yearly. The legislation focuses on advancing scientific understanding to improve prevention and treatment, citing the high mortality rate (50% fatal) and significant healthcare costs ($4.1 billion annually in direct costs) associated with brain aneurysm ruptures.
HR 949, the Insular Area Medicaid Parity Act, removes federal funding caps on Medicaid for U.S. territories, directly affecting Puerto Rico, the U.S. Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa. The bill amends the Social Security Act to eliminate the existing limit on federal Medicaid funding for these territories, allowing them to receive full federal matching funds like states. This change takes effect for fiscal year 2023, ending the previous restriction that required territories to fund a portion of their Medicaid costs themselves. The policy change ensures these territories can access the same level of federal Medicaid support as states.
Kids' Access to Primary Care Act of 2023 This bill modifies payments for Medicaid primary care services. Specifically, the bill applies a Medicare payment rate floor to Medicaid primary care services that are provided after the date of enactment of the bill and extends the payment rate to additional types of practitioners (e.g., obstetricians). The Centers for Medicare & Medicaid Services must conduct a study on the number of children enrolled in Medicaid, the number of providers receiving payment for primary care services, and associated payment rates before and after the bill's implementation.
HR 972, the Outpatient Surgery Quality and Access Act of 2023, updates Medicare payment rules for outpatient surgery centers and hospital outpatient departments. It requires Medicare to publicly compare quality data for these facilities in the same geographic area on Medicare.gov, allows facilities to review data before release, and mandates that the Secretary cite specific criteria when excluding procedures from coverage. The bill also caps patient out-of-pocket costs for outpatient surgery at the hospital deductible amount and aligns annual payment updates between surgery centers and hospitals. These changes aim to improve transparency for beneficiaries and standardize payment adjustments.
The HELP Copays Act (HR 830) changes how health insurance plans calculate patient cost-sharing. It requires that payments made by third parties (like pharmacies, charities, or discount programs) toward medical costs count toward a patient's deductible, copay, or out-of-pocket limit. This directly affects insured individuals who receive financial assistance, discounts, or product vouchers for healthcare expenses. The law ensures these external payments reduce the patient's actual out-of-pocket costs more quickly, aligning with existing Affordable Care Act and Public Health Service Act requirements.
SRES 66 is a Senate resolution condemning China's use of a high-altitude surveillance balloon over U.S. territory as a violation of U.S. sovereignty. It specifically denounces China's false claims that the balloon was a weather device that drifted off course. The resolution requires the President to provide Congress with detailed briefings on the incident, including the balloon's timeline, intelligence gathered, and plans to prevent future violations of U.S. airspace. It calls for decisive U.S. action to deter foreign surveillance activities and holds the Chinese government accountable for such actions.
This bill requires any U.S. agreement with Iran regarding its nuclear program to be treated as a treaty, mandating Senate approval by a two-thirds vote before it can take effect. It directly affects the President, who cannot bypass this requirement to waive or reduce sanctions related to Iran's nuclear activities. The key provision blocks the President from granting sanctions relief or taking related actions under any Iran nuclear deal - including joint plans, side agreements, or future documents - without first securing Senate treaty approval. This applies to all forms of agreements, whether legally binding or not, and covers all related materials like annexes or technical understandings.
This bill restricts the executive branch's authority to pause or cancel federal student loan payments during national emergencies. It prohibits the President or Secretary of Education from suspending payments or canceling balances for borrowers with household incomes above 400% of the poverty line during emergencies, and bans executive actions to cancel loans related to the COVID-19 pandemic or other emergencies. Any such pause or cancellation would be treated as a "major rule" requiring congressional review under the Congressional Review Act. The bill primarily affects higher-income borrowers during emergencies by limiting executive relief options, while maintaining existing loan programs for lower-income borrowers. It does not change standard loan repayment terms but restricts emergency executive actions.
This bill amends U.S. immigration law to create specific, limited pathways for temporary parole into the United States. It directly affects military families (spouses/children of active-duty service members), Cuban nationals with approved petitions meeting strict criteria, and individuals facing urgent medical needs, family emergencies, or law enforcement-related public benefits. Key provisions require case-by-case decisions (not class-based eligibility), limit parole to 1 year (with possible 1-year extensions), and mandate annual congressional reporting on parole usage. Parole does not count as admission, so recipients cannot adjust to permanent residency through this status.
